个人简介
1994年毕业于中山医科大学，2000年获肿瘤学硕士学位，从事肿瘤临床、教学和科研工作23年。擅长各种恶性肿瘤的化疗，尤其是肺癌的化疗。
近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Houttuyninum, an active constituent of Chinese herbal medicine, inhibits phosphorylation of HER2/neu receptor tyrosine kinase and the tumor growth of HER2/neu-overexpressing cancer cells. Zhou NN, Tang J, Chen WD, Feng GK, Xie BF, Liu ZC, Yang D, Zhu XF. Life Sci. 2012 May 22;90(19-20):770-5. doi: 10.1016/j.lfs.2012.03.035. Epub 2012 Apr 13. 周宁宁第一作者 Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) non-small cell lung cancer. Xia Q, Zhu Z, Wang J, Situ D, Zhou N, Jang W. Tumour Biol. 2012 Oct;33(5):1719-25. doi: 10.1007/s13277-012-0429-9. Epub 2012 Jun 27.下情 周宁宁（通讯作者） Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin-based chemotherapy. Gao H, Liang Y, Zhou N, Zhang D, Wu H. Intern Med J. 2011 Dec 5. doi: 10.1111/j.1445-5994.2011.02637.x. [Epub ahead of print] PMID: 22141732 [PubMed - as supplied by publisher] Related citations Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer. Wang F, Wang Z, Zhou N, An X, Xu R, He Y, Li Y. Am J Clin Oncol. 2011 Aug;34(4):401-5.
京公网安备 11010802027423号